Pivotal role for platelet-activating factor receptor in CD36 expression and oxLDL uptake by human monocytes/macrophages

Cellular Physiology and Biochemistry

Volumn 27, Issue 3-4, 2011, Pages 363-372

  Rios, Francisco J O ^a   Gidlund, Magnus ^a   Jancar, Sonia ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

Atherosclerosis; CD36; Foam cells; Macrophages; OxLDL; Platelet Activating Factor Receptor

Indexed keywords

2 (2 AMINO 3 METHOXYPHENYL)CHROMONE; 4 (4 FLUOROPHENYL) 2 (4 METHYLSULFINYLPHENYL) 5 (4 PYRIDYL)IMIDAZOLE; ANTHRA[1,9 CD]PYRAZOL 6(2H) ONE; BEPAFANT; CD36 ANTIGEN; FLUORESCEIN ISOTHIOCYANATE; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; OXIDIZED LOW DENSITY LIPOPROTEIN; THROMBOCYTE ACTIVATING FACTOR RECEPTOR; [2 METHOXY 3 (N OCTADECYLCARBAMOYLOXY)PROPYL] (2 THIAZOLIOETHYL) PHOSPHATE;

ARTICLE; CELL ADHESION; CELL INTERACTION; CELL STIMULATION; FLOW CYTOMETRY; HUMAN; HUMAN CELL; MACROPHAGE; MONOCYTE; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; UPREGULATION; WESTERN BLOTTING; WILD TYPE;

MUS;

EID: 79953773696     PISSN: 10158987     EISSN: None     Source Type: Journal    
DOI: 10.1159/000327962     Document Type: Article

References (30)

1. Febbraio M, Silverstein RL: Cd36: Implications in cardiovascular disease. Int J Biochem Cell Biol 2007;39:2012-2030. (Pubitemid 47376825)
2. Feng J, Han J, Pearce SF, Silverstein RL, Gotto AM, Hajjar DP, Nicholson AC: Induction of cd36 expression by oxidized ldl and il-4 by a common signaling pathway dependent on protein kinase c and ppar-gamma. J Lipid Res 2000;41:688-696.
3. Endemann G, Stanton LW, Madden KS, Bryant CM, White RT, Protter AA: Cd36 is a receptor for oxidized low density lipoprotein. J Biol Chem 1993;268:11811-11816. (Pubitemid 23168135)
4. Nagy L, Tontonoz P, Alvarez JG, Chen H, Evans RM: Oxidized ldl regulates macrophage gene expression through ligand activation of ppargamma. Cell 1998;93:229-240. (Pubitemid 28180856)
5. Nozaki S, Kashiwagi H, Yamashita S, Nakagawa T, Kostner B, Tomiyama Y, Nakata A, Ishigami M, Miyagawa J, Kameda-Takemura K: Reduced uptake of oxidized low density lipoproteins in monocyte-derived macrophages from cd36-deficient subjects. J Clin Invest 1995;96:1859-1865.
6. Febbraio M, Podrez EA, Smith JD, Hajjar DP, Hazen SL, Hoff HF, Sharma K, Silverstein RL: Targeted disruption of the class b scavenger receptor cd36 protects against atherosclerotic lesion development in mice. J Clin Invest 2000;105:1049-1056. (Pubitemid 30217689)
7. Tontonoz P, Nagy L, Alvarez JG, Thomazy VA, Evans RM: Ppargamma promotes monocyte/macrophage differentiation and uptake of oxidized ldl. Cell 1998;93:241-252. (Pubitemid 28180857)
8. Schackelford RE, Misra UK, Florine-Casteel K, Thai SF, Pizzo SV, Adams DO: Oxidized low density lipoprotein suppresses activation of nf kappa b in macrophages via a pertussis toxin-sensitive signaling mechanism. J Biol Chem 1995;270:3475-3478.
9. Marathe GK, Prescott SM, Zimmerman GA, McIntyre TM: Oxidized ldl contains inflammatory paf-like phospholipids. Trends Cardiovasc Med 2001;11:139-142. (Pubitemid 33070337)
10. Svensjo E, Boschcov P, Ketelhuth DF, Jancar S, Gidlund M: Increased microvascular permeability in the hamster cheek pouch induced by oxidized low density lipoprotein (oxldl) and some fragmented apolipoprotein b proteins. Inflamm Res 2003;52:215-220. (Pubitemid 36712966)
11. Ishii S, Nagase T, Shimizu T: Platelet-activating factor receptor. Prostaglandins Other Lipid Mediat 2002;68-69:599-609. (Pubitemid 35247423)
12. Nakamura M, Honda Z, Izumi T, Sakanaka C, Mutoh H, Minami M, Bito H, Seyama Y, Matsumoto T, Noma M, Shimizuj T: Molecular cloning and expression of platelet-activating factor receptor from human leukocytes. J Biol Chem 1991;266:20400-20405. (Pubitemid 21908472)
13. de Oliveira SI, Fernandes PD, Amarante Mendes JG, Jancar S: Phagocytosis of apoptotic and necrotic thymocytes is inhibited by paf-receptor antagonists and affects lps-induced cox-2 expression in murine macrophages. Prostaglandins Other Lipid Mediat 2006;80:62-73. (Pubitemid 44038606)
14. Rios FJ, Jancar S, Melo IB, Ketelhuth DF, Gidlund M: Role of ppar-gamma in the modulation of cd36 and fcgammarii induced by ldl with low and high degrees of oxidation during the differentiation of the monocytic thp-1 cell line. Cell Physiol Biochem 2008;22:549-556.
15. Fremont L, Belguendouz L, Delpal S: Antioxidant activity of resveratrol and alcohol-free wine polyphenols related to ldl oxidation and polyunsaturated fatty acids. Life Sci 1999;64:2511-2521. (Pubitemid 29268427)
16. Carvalho MD, Vendrame CM, Ketelhuth DF, Yamashiro-Kanashiro EH, Goto H, Gidlund M: High-density lipoprotein inhibits the uptake of modified low- density lipoprotein and the expression of cd36 and fcgammari. J Atheroscler Thromb 2010;17:844-857.
17. Sakai H, Kaneshige H, Endoh M: Determination of ldl receptors on cultured lymphocytes using fluorescein-labeled ldl. Am J Clin Pathol 1982;78:58-62. (Pubitemid 12093120)
18. Ishii S, Kuwaki T, Nagase T, Maki K, Tashiro F, Sunaga S, Cao WH, Kume K, Fukuchi Y, Ikuta K, Miyazaki J, Kumada M, Shimizu T: Impaired anaphylactic responses with intact sensitivity to endotoxin in mice lacking a platelet-activating factor receptor. J Exp Med 1998;187:1779-1788. (Pubitemid 28262442)
19. Heuer HO, Casals-Stenzel J, Muacevic G, Weber KH: Pharmacologic activity of bepafant (web 2170), a new and selective hetrazepinoic antagonist of platelet activating factor. J Pharmacol Exp Ther 1990;255:962-968.
20. Terashita Z, Imura Y, Nishikawa K: Inhibition by cv-3988 of the binding of [3h]-platelet activating factor (paf) to the platelet. Biochem Pharmacol 1985;34:1491-1495.
21. Taketa K, Matsumura T, Yano M, Ishii N, Senokuchi T, Motoshima H, Murata Y, Kim-Mitsuyama S, Kawada T, Itabe H, Takeya M, Nishikawa T, Tsuruzoe K, Araki E: Oxidized low density lipoprotein activates peroxisome proliferator-activated receptor-alpha (pparalpha) and ppargamma through mapk-dependent cox-2 expression in macrophages. J Biol Chem 2008;283:9852-9862.
22. Zhao M, Liu Y, Wang X, New L, Han J, Brunk UT: Activation of the p38 map kinase pathway is required for foam cell formation from macrophages exposed to oxidized ldl. APMIS 2002;110:458-468. (Pubitemid 34856488)
23. Ricci R, Sumara G, Sumara I, Rozenberg I, Kurrer M, Akhmedov A, Hersberger M, Eriksson U, Eberli FR, Becher B, Boren J, Chen M, Cybulsky MI, Moore KJ, Freeman MW, Wagner EF, Matter CM, Luscher TF: Requirement of jnk2 for scavenger receptor a-mediated foam cell formation in atherogenesis. Science 2004;306:1558-1561. (Pubitemid 39564952)
24. Marathe GK, Davies SS, Harrison KA, Silva AR, Murphy RC, Castro-Faria-Neto H, Prescott SM, Zimmerman GA, McIntyre TM: Inflammatory platelet-activating factor-like phospholipids in oxidized low density lipoproteins are fragmented alkyl phosphatidylcholines. J Biol Chem 1999;274:28395-28404.
25. Yang CM, Chien CS, Hsiao LD, Pan SL, Wang CC, Chiu CT, Lin CC: Mitogenic effect of oxidized low-density lipoprotein on vascular smooth muscle cells mediated by activation of ras/raf/mek/mapk pathway. Br J Pharmacol 2001;132:1531-1541.
26. Jing Q, Xin SM, Cheng ZJ, Zhang WB, Zhang R, Qin YW, Pei G: Activation of p38 mitogen-activated protein kinase by oxidized ldl in vascular smooth muscle cells: Mediation via pertussis toxin-sensitive g proteins and association with oxidized ldl-induced cytotoxicity. Circ Res 1999;84:831-839. (Pubitemid 29181490)
27. Brown SL, Jala VR, Raghuwanshi SK, Nasser MW, Haribabu B, Richardson RM: Activation and regulation of platelet-activating factor receptor: Role of g(i) and g(q) in receptor-mediated chemotactic, cytotoxic, and cross-regulatory signals. J Immunol 2006;177:3242-3249. (Pubitemid 44277843)
28. Subbanagounder G, Leitinger N, Shih PT, Faull KF, Berliner JA: Evidence that phospholipid oxidation products and/or platelet-activating factor play an important role in early atherogenesis : In vitro and in vivo inhibition by web 2086. Circ Res 1999;85:311-318. (Pubitemid 29398863)
29. Dentan C, Lesnik P, Chapman MJ, Ninio E: Phagocytic activation induces formation of platelet-activating factor in human monocyte-derived macrophages and in macrophage-derived foam cells. Relevance to the inflammatory reaction in atherogenesis. Eur J Biochem 1996;236:48-55. (Pubitemid 26074859)
30. Brocheriou I, Stengel D, Mattsson-Hulten L, Stankova J, Rola-Pleszczynski M, Koskas F, Wiklund O, Le Charpentier Y, Ninio E: Expression of platelet-activating factor receptor in human carotid atherosclerotic plaques: Relevance to progression of atherosclerosis. Circulation 2000;102:2569-2575.